delgocitinib
leo pharma
['delgocitinib', 'leo pharma']
leo pharma presents late-breaking positive phase 3 results of delgocitinib cream in adults with moderate to severe chronic hand eczema (che) at aad 2023 
Breaking news from Business Wire